Amagi Media Labs' public offering is showing a small boost in market optimism, with the grey market premium (GMP) nudging up to about 6%.
What the IPO Looks Like
The company is offering shares worth roughly Rs 1,789 crore. The price band is set between Rs 343 and Rs 361 per share. The issue combines a fresh issue of Rs 816 crore and an offer‑for‑sale (OFS) of Rs 973 crore by existing shareholders.
Subscription Snapshot
- Overall subscription on the first day was only 6%.
- Retail individual investors (RIIs) took up 28% of the 50.73 lakh shares allotted to them.
- Non‑institutional investors (NIIs) subscribed just 4% of their quota.
- Qualified institutional buyers (QIBs) placed no bids for the 1.45 crore shares reserved for them.
Grey Market Premium (GMP)
The GMP has moved from around 4% on day one to almost 6% today, which translates to roughly Rs 20 above the issue price of Rs 361. At this premium, the shares could list near Rs 381.
Business Overview
Amagi works in the fast‑growing connected TV (CTV) and programmatic advertising space. It helps advertisers reach viewers on streaming platforms and assists publishers in monetising their digital inventory. The company has a strong presence in the United States, where CTV ad spend is rising.
Use of Funds
- About Rs 550 crore will go toward strengthening technology and cloud infrastructure.
- The remaining amount will fund possible acquisitions and general corporate needs.
Financial Highlights
- Revenue for FY25 was Rs 1,223 crore, up ~30% from Rs 942 crore in FY24.
- The firm narrowed its losses in FY25 and posted a modest profit of Rs 6.47 crore in the first half of FY26.
Risks to Consider
- Advertising budgets can shrink during economic slowdowns.
- Currency fluctuations and dependence on a few large clients add uncertainty.
- Intense competition in the global ad‑tech market.
Analyst Viewpoint
Brokerages suggest treating the IPO as a medium‑ to long‑term investment rather than a quick‑gain play. While Amagi’s position in the growing CTV ad space and its improving financials are positives, valuation comfort and the overall market mood could limit immediate listing gains.
Key Dates
- Subscription closes: 16 January 2026
- Allotment expected: 19 January 2026
- Listing (BSE & NSE) tentative: 21 January 2026
Remember, this is perspective, not prediction. Do your own research before deciding to invest.